Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia.
Autor: | Abd El-Rady NM; Physiology Department, Faculty of Medicine, Assiut University, Assiut, Egypt., Ahmed A; Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Egypt., Abdel-Rady MM; Anesthesia and Intensive Care Department, Faculty of Medicine, Assiut University, Assiut, Egypt., Ismail OI; Department of Human Anatomy and Embryology, Faculty of Medicine, Assiut University, Assiut, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Physiological reports [Physiol Rep] 2021 Jan; Vol. 8 (24), pp. e14651. |
DOI: | 10.14814/phy2.14651 |
Abstrakt: | Background: Alzheimer's disease (AD) is a worldwide severe medical and social burden. Liraglutide (LIR) has neuroprotective effects in preclinical animal models. Aim: To explore the probable neuroprotective impact of Glucagon-like peptide-1 (GLP-1) on rats' behavior and to elucidate its underlying mechanisms. Methods: A total of 24 male albino rats were assigned to control, LIR (300 µg/kg subcutaneously (s.c.)), AD only (100 mg/kg aluminum chloride (AlCl Results: LIR prevents the impairment of learning and improves both working memory and reference memory through significant reduction of serum tumor necrosis factor (TNF-α), interleukin 6 (IL-6) and interferon-γ (INF-γ) and malondialdehyde (MDA) and through the increase of superoxide dismutase (SOD), dopamine, adrenaline, and noradrenaline. LIR also improves hippocampal histological features of ALCL Conclusion: LIR normalizes ALCL (© 2020 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |